A prostate cancer test is best taken on a regular basis from the age of forty. A yearly test is generally enough due to the slow growing nature of Prostate cancer. By conducting check ups, the detection of the disease can be completed at a very early stage and needless to say, that the early stage detection might even give complete cure.
John Hopkins Oncology Scientists and researches have found out a method to measure prostate cancer at a very early stage: Prostate cancer triggers certain genetic changes. If the chemical process associated with genetic change is measured, detection of prostate cancer becomes a possibility even at a very early stage. Early stage detection ensures complete cure of the malaise.
U.S and U.K scientists are developing a test for prostate cancer using a sample of prostate fluid taken through a needle inserted under local anesthetic and takes less than three minutes to complete. This will be a boon to the patients, health officials and Doctors. A Prasanna de Silva, chair of the organic chemistry at Queen’s University Belfast, U.K said that the new test was: ” A convenient and quick method which provides early warning of prostate cancer which will bring relief to many men”.
The most popular test for cancer throughout the world is the Prostate specific Antigen (PSA) prostate cancer test. Prostate gland secretes a protein called PSA and if the secretion value is high, it is indicative of the presence of cancer forming cells. This test along with Digital Rectal Examination helps Physician to accurately measure the size of the prostate gland.
Pharmaceuticals Scientists based at Maryland have identified a protein – HAAH enzyme might prove to be a biomarker, the sensitivity and specificity of which is much more accurate than the current methods for cancer detection. This biomarker test will detect cancer very fast and hence will be useful in preventing prostate cancer recurrence.
Swedish medical University Karolinska Institutet scientists have identified risk genes through a simple DNA test and hope that men carrying a known combination of risk genes run 4 to 5 times higher risk of prostate cancer. They say that the risk of prostate cancer recurrence is there even in the cases of unfinished cures.
Now let us look at the nanoparticle prostate cancer test. Here the golden nanoparticles are first mixed in a solution. Then the patrient’s blood is dropped in the nano solution. Then the nano particles seek put the protein. In case of protein particles being present, then the protein particles surrounded by the nanoparticles. When there is cluster formation, cancer is present, is the inference. Otherwise in case of no cluster formation, obviously no cancer formation needs to be suspected.
Is being obese, an obstruction for an accurate Prostate cancer test? Texas University Health Science Center in San Antonio, came to the conclusion that in obese men, the sensitivity of PSA testing is being blunted. Doctors believe that obese men produce more estrogen, which drives down testosterone levels and could affect cells that produce antigen in the test.